AIT-082.  "Drugs of the Future."  Drugs of the Future. 1997, 22(9): 945-947.

Budavari, Susan ed.  The Merck Index 12th Ed.  Merck & Co., Inc.  Whitehouse Station.  1996.

Deutscher, Murray ed. Methods in Enzymomolgy: Guide to Protein Purification Vol. 182.  Academic Press, Inc. San Diego. 1990.

Elo, H. A., Pauli Ylitalo, Jaana Kyottila, and Heikki Hervonen.  " Increase in the penetration of tracer compounds into the rat brain during 2-methyl-4-chlorophenoxyacetic acid (MCPA) intoxication."  Acta pharmacol et toxicol.  1982, 50: 104-107.

Finklestein, H.  Ber. 43, 1528 (1910).

GenomeNet.  "Ligand 1.14.13.27."  <http://www.genome.ad.jp/dbget-bin/www_bget?ligand+1.14.13.27> (Mar. 20, 1999).

GenomeNet.  "Ligand 2.5.1.15."  < http://www.genome.ad.jp/dbget-bin/www_bget?ligand+2.5.1.15> (Mar. 20, 1999)

Glasky, Alvin J.  W.O. Patent 96/03125.  1996.

Glasky, Alvin J.  U.S. Patent 5,091,432.  1992.

Gupta, A., T. Malati, and P. D. Gupta.  "Altered expression of keratin in epithelioid tumors."  Current Science (Bangalore).  1992, 62(3): 288-293.

Manzke, H. and H. Gustmann.  "Reduced urinary serotonin excretion after intake of high does of hypoxanthine."  Europe Journal of Pediatrics.  1989, 148(4): 337-340.

Martignoni, E., G. Bono, F. Blandini, E. Sinforianu, P. Merlo, and G. Nappi.  "Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type: Influence of treatment with L-deprenyl."  Journal of Neural Transmission Parkinsonís Disease and Dementia.  1991, 3(1): 15-26.

Neotherapeutics Inc.  "AIT-082 and its surrounding technology."  <http://www.neotherapeutics.com/ait082.html> (Dec. 12, 1997).

Neotherapeutics Inc.  "First patients dosed in phase I study on new class of drugs for Alzheimerís disease."  <http://www.neottherapeutics.com/r970714.html> (Dec. 12, 1997).

Pert, C. B., S. H. Snyder.  "Opiate receptor demonstrations in nervous tissue."  Science.  1973, 179: 1011-1014.

Premachandra, B. R.  "Interaction of p-aminobenzoic acid with erythrocyte membrane: photoaffinity labeling of the binding sites."  Biochemical Medicine and Metabolic Biology.  1989, 41: 1-17.

Rapoport, S. I.  Blood-brain barrier in physiology and medicine.  Raven Press, New York, 1976.

Regland, B. and C. G. Gottfries.  "Slowed synthesis of DNA and methionine is a pathogenetic mechanism common to dementia in Downís syndrome, AIDS, and Alzheimerís disease?"  Medical Hypotheses.  1992, 38(1): 11-19.
Rotenberg, M. O. and M.D. Maines.  "Characterization of a complementary DNA-encoding rabbit brain heme oxygenase-2 and identification of a conserved domain among mammalian heme oxygenase isozymes: Possible heme-binding site."  Archives of Biochemistry and Biophysics.  1991, 290(2): 336-344.

Rublevskaya, I. and M. Maines.  "Interaction of fe-protoporphyrin IX and heme analogues with purified recombinant heme oxygenase-2, the constitutive isozyme of the brain and testes."  Journal of Biological Chemistry. 1994, 269(42): 26390-26395.

Serfass, L. and J. Burstyn.  ë Effect of heme oxygenase inhibitors on soluble guanylyl cyclase activity."  Archives of Biochemistry and Biophysics.  1998, 359(1): 8-16.

Schotten, C.  Ber. 17, 2544 (1884).

Spector, R.  "Hypoxanthine transport through the blood-brain barrier."  Neurochemical Research.  1987, 12(9): 791-796.

Storga, D., K. Vrecko, J. G. Birkmayer, and G. Reibnegger.  "Monoaminergic neurotransmitters, their precursors, and metabolites in brains of Alzheimerís patients."  Neuroscience Letters.  1996, 203(1): 29-32.

Talarico, T. L., I. K. Dev, W. S. Dallas, R. Ferone, and P. H. Ray.  "Purification and partial characterization of 7,8-dihydro-6-hydroxymethylpterin-pyrophosphokinase and 7,8-dihydropteroate synthase from Escherichia coli MC4100."  Journal of Bacteriology.  1991, 173(21); 7029-7032.

Tshuji, H., t. Ogawa, N. Bando, and K. Sasaoka.  "Purification and properties of 4-aminobenzoate hydroxylase, a new monooxygenase from Agaricus bisporus."  Journal of Biological Chemistry.  1986, 261(28): 13203-13209.